InvestorsHub Logo
Followers 4
Posts 1195
Boards Moderated 0
Alias Born 10/03/2015

Re: NY1972 post# 148

Sunday, 03/20/2016 3:29:58 PM

Sunday, March 20, 2016 3:29:58 PM

Post# of 977
Hu5F9-G4 has substantial efficacy in MES-OV OCX, and at least additive effects with chemotherapy (Ptx and Carbo) and immunotherapy (Cetux and Trastuz).

http://www.abstractsonline.com/Plan/ViewAbstract.aspx?sKey=d11dcb99-938f-4e14-ab7a-f7b01af6261a&cKey=da65739c-ebcf-4997-add0-0446e937826f&mKey=1d10d749-4b6a-4ab3-bcd4-f80fb1922267